Haloperidol-loaded lipid-core polymeric nanocapsules reduce DNA damage in blood and oxidative stress in liver and kidneys of rats
Haloperidol-loaded lipid-core polymeric nanocapsules reduce DNA damage in blood and oxidative stress in liver and kidneys of rats
复制标题
氟哌啶醇脂质核心聚合物纳米胶囊减少大鼠血液中的 DNA 损伤以及肝脏和肾脏的氧化应激
DOI:
10.1007/s11051-015-2979-4
复制
发表时间:
2015
影响因子:
2.5
通讯作者:
M. Burger
中科院分区:
文献类型:
--
作者:
Katiane Roversi;D. Benvegnú;K. Roversi;F. Trevizol;L. T. Vey;F. Elias;R. Fracasso;M. Motta;R. F. Ribeiro;Bruna S. Hausen;R. Moresco;S. Garcia;Cristiane B. Silva;M. Burger
Haloperidol (HP) nanoencapsulation improves therapeutic efficacy, prolongs the drug action time, and reduces its motor side effects. However, in a view of HP toxicity in organs like liver and kidneys in addition to the lack of knowledge regarding the toxicity of polymeric nanocapsules, our aim was to verify the influence of HP-nanoformulation on toxicity and oxidative stress markers in the liver and kidneys of rats, also observing the damage caused in the blood. For such, 28 adult male Wistar rats were designated in four experimental groups (n = 7) and treated with vehicle (C group), free haloperidol suspension (FH group), blank nanocapsules suspension (B-Nc group), and haloperidol-loaded lipid-core nanocapsules suspension (H-Nc group). The nanocapsules formulation presented the size of approximately 250 nm. All suspensions were administered to the animals (0.5 mg/kg/day-i.p.) for a period of 28 days. Our results showed that FH caused damage in the liver, evidenced by increased lipid peroxidation, plasma levels of aspartate aminotransferase, and alanine aminotransferase, as well as decreased cellular integrity and vitamin C levels. In kidneys, FH treatment caused damage to a lesser extent, observed by decreased activity of δ-aminolevulinate dehydratase (ALA-D) and levels of VIT C. In addition, FH treatment was also related to a higher DNA damage index in blood. On the other hand, animals treated with H-Nc and B-Nc did not show damage in liver, kidneys, and DNA. Our study indicates that the nanoencapsulation of haloperidol was able to prevent the sub-chronic toxicity commonly observed in liver, kidneys, and DNA, thus reflecting a pharmacological superiority in relation to free drug.
DOI:
10.1159/000459097
发表时间:
1982-01-01
期刊:
ENZYME
影响因子:
--
作者:
SASSA, S
通讯作者:
SASSA, S
DOI:
--
发表时间:
1994
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Rollema,H;Skolnik,M;D'Engelbronner,J;Igarashi,K;Usuki,E;CastagnoliJr,N
通讯作者:
CastagnoliJr,N
DOI:
10.1021/tx960001y
发表时间:
1996
期刊:
Chemical research in toxicology.
影响因子:
--
作者:
Usuki,E;Pearce,R;Parkinson,A;CastagnolJr,N
通讯作者:
CastagnolJr,N